Zobrazeno 1 - 10
of 444
pro vyhledávání: '"BA.2"'
Autor:
Myriam Drysdale, Holly Tibble, Vishal Patel, Daniel C. Gibbons, Emily J. Lloyd, William Kerr, Calum Macdonald, Helen J. Birch, Aziz Sheikh
Publikováno v:
BMC Infectious Diseases, Vol 24, Iss 1, Pp 1-10 (2024)
Abstract Background The clinical benefit of coronavirus disease 2019 (COVID-19) treatments against new circulating variants remains unclear. We sought to describe characteristics and clinical outcomes of highest risk patients with COVID-19 receiving
Externí odkaz:
https://doaj.org/article/e6f97d2fec77487f82c4dc9b302868dd
Publikováno v:
Infection and Drug Resistance, Vol Volume 17, Pp 1467-1476 (2024)
Wei Wu,1– 4,* Wenbin Lu,5,* Dongmei Hong,1– 4 Xiya Yu,1– 4 Lize Xiong1– 4 1Shanghai Key Laboratory of Anesthesiology and Brain Functional Modulation, Shanghai, 200434, People’s Republic of China; 2Department of Anesthesiology and Pe
Externí odkaz:
https://doaj.org/article/9812b85d516b4bb69e6564f5a525355a
Autor:
Suman Dhankher, Pooja Yadav, Shashi Sharma, Ekta Gupta, Ram Govind Yadav, Paban Kumar Dash, Manmohan Parida
Publikováno v:
Frontiers in Medicine, Vol 11 (2024)
The SARS-CoV-2 Omicron (B.1.1.529) variant emerged in early November 2021 and its rapid spread created fear worldwide. This was attributed to its increased infectivity and escaping immune mechanisms. The spike protein of Omicron has more mutations (>
Externí odkaz:
https://doaj.org/article/07477f7f3e5a4ae587af7921a4eb72df
Publikováno v:
BMC Infectious Diseases, Vol 24, Iss 1, Pp 1-10 (2024)
Abstract Background The latent and incubation periods characterize the transmission of infectious viruses and are the basis for the development of outbreak prevention and control strategies. However, systematic studies on the latent period and associ
Externí odkaz:
https://doaj.org/article/d72e62ec698a481e8b870f829de46cf2
Autor:
Alwaleed Behzad, Aamal Mohamed, Ahmed Ali, Sara Niinuma, Alexandra E. Butler, Manaf Alqahtani
Publikováno v:
Journal of Infection and Public Health, Vol 17, Iss 2, Pp 315-320 (2024)
Background: Laboratory-based evidence indicates that neutralization of the BA.2 (Omicron) variant by sotrovimab is reduced versus previous SARS-CoV-2 variants. Since there is a lack of real-world data, we investigated whether sotrovimab has reduced c
Externí odkaz:
https://doaj.org/article/cdb6597c8d104f9fbdc059c487d08971
Autor:
Carson K. L. Lo, Calvin K. F. Lo, Adam S. Komorowski, Victor Leung, Nancy Matic, Susan McKenna, Santiago Perez-Patrigeon, Prameet M. Sheth, Christopher F. Lowe, Zain Chagla, Anthony D. Bai
Publikováno v:
BMC Research Notes, Vol 17, Iss 1, Pp 1-6 (2024)
Abstract Background In vitro data suggested reduced neutralizing capacity of sotrovimab, a monoclonal antibody, against Omicron BA.2 subvariant. However, limited in vivo data exist regarding clinical effectiveness of sotrovimab for coronavirus diseas
Externí odkaz:
https://doaj.org/article/2aace75244d9486bbb5f42ff68cead0c
Autor:
Rayane Rafei, Layla Tajer, Dalal Nour, Karen Abboud, Dima Ankoud, Marwan Osman, Marielle Bedotto, Mohamad Bachar Ismail, Fouad Dabboussi, Philippe Colson, Monzer Hamze
Publikováno v:
Pathogens, Vol 13, Iss 10, p 872 (2024)
This study aimed to investigate the SARS-CoV-2 infection prevalence among >18-year-old students in the Faculty of Public Health and Faculty of Sciences at the Lebanese University in Tripoli, Northern Lebanon, in June 2023 and to characterize the circ
Externí odkaz:
https://doaj.org/article/454572daa4154d549c3e451e8d18c47b
Autor:
Yuxue Liao, Jiao Su, Jieru Zhao, Zhen Qin, Zhuo’Ao Zhang, Wei Gao, Jia Wan, Yi Liao, Xuan Zou, Xiaofeng He
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
Little studies evaluated the effectiveness of booster vaccination of inactivated COVID-19 vaccines against being infected (susceptibility), infecting others (infectiousness), and spreading the disease from one to another (transmission). Therefore, we
Externí odkaz:
https://doaj.org/article/c3da519c34c94e0786b73e155009bcd7
Autor:
Haruka Maeda, Nobuo Saito, Ataru Igarashi, Masayuki Ishida, Mayumi Terada, Takayasu Ito, Hideko Ikeda, Hiroshi Kamura, Iori Motohashi, Yuya Kimura, Masaru Komino, Hiromi Arai, Osamu Kuwamitsu, Nobuhiro Akuzawa, Eiichiro Sando, Toru Morikawa, Haruki Imura, Hiroki Inoue, Tomoichiro Hayakawa, Osamu Teshigahara, Yasuji Ohara, Motoi Suzuki, Konosuke Morimoto
Publikováno v:
Expert Review of Vaccines, Vol 22, Iss 1, Pp 288-298 (2023)
Background Evaluating COVID-19 vaccine effectiveness (VE) domestically is crucial for assessing and determining national vaccination policy. This study aimed to evaluate VE of mRNA COVID-19 vaccines in Japan. Methods We conducted a multicenter test-n
Externí odkaz:
https://doaj.org/article/c5e2c260b54845e1b8297de267718e84
Autor:
Chan Liu, Jianhua Lu, Peihua Li, Siyang Feng, Yichao Guo, Kangguo Li, Benhua Zhao, Yanhua Su, Tianmu Chen, Xuan Zou
Publikováno v:
International Journal of Infectious Diseases, Vol 134, Iss , Pp 78-87 (2023)
Objectives: The Omicron BA.2 variant is probably the main epidemic strain worldwide at present. Comparing the epidemiological characteristics, transmissibility, and influencing factors of SARS-CoV-2, the results obtained in this paper will help to pr
Externí odkaz:
https://doaj.org/article/8af3cd86572a495ebb77372e55fb85aa